REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 91 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Office Administrative Services
Full name: Dr.Max 91 S.R.O. Profile Updated: July 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 91 S.R.O. is an enterprise in Slovakia, with the main office in Kosice. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on May 06, 2015. 5 - 9 (2025) employees currently work for Dr.Max 91 S.R.O.. In its most recent financial highlights, the company reported a net sales revenue increase of 26.43% in 2024. A growth of 19.57% was recorded in its total assets. The net profit margin of Dr.Max 91 S.R.O. decreased by 0.36% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 91 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 91 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 91 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 91 S.R.O. report to view the information.
Incorporation Date:
May 06, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 91 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
26.43%▲
Total operating revenue
26.42%▲
Operating profit (EBIT)
-7.96%▼
EBITDA
-5.78%▼
Net Profit (Loss) for the Period
-2.22%▼
Total assets
19.57%▲
Total equity
13.03%▲
Operating Profit Margin (ROS)
-0.51%▼
Net Profit Margin
-0.36%▼
Return on Equity (ROE)
-1.8%▼
Debt to Equity Ratio
-0.35%▼
Quick Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo